MedPath
NMPA Approval

Linezolid for Oral Suspension

国药准字HJ20170247

辉瑞

September 2, 2021

H20170247

Drug Information

利奈唑胺干混悬剂

斯沃

口服混悬剂

5ml:100mg(每瓶含利奈唑胺3g)

化学药品

September 2, 2021

September 1, 2026

Company Information

Applicant Company

辉瑞

66 Hudson Boulevard East, New York, NY 10001 United States of America

Manufacturing Company

neolpharma,inc.

99 Jardines Street, Caguas, Puerto Rico 00725

© Copyright 2025. All Rights Reserved by MedPath